| Name | Title | Contact Details |
|---|
Ritter Pharmaceuticals, Inc. is a specialty pharmaceutical company developing therapeutics based upon colonic adaptation to treat gastrointestinal diseases with an initial focus on lactose intolerance. Colonic adaptation improves colon function by selectively increasing the growth of beneficial bacteria in the colonic ecosystem (digestive tract). Ritter Pharmaceuticals, Inc. is rapidly establishing itself as the world`s leader in lactose intolerance research based upon its scientific team and their cutting edge research in this field. RP-G28, Ritter`s lead product, has been studied in a Phase 2 trial and is a first-in-class compound. RP-G28 has the potential to become the first FDA-approved drug for the treatment of lactose intolerance, a debilitating disease which affects over 1 billion people worldwide.
Tampa, Florida-based TrueCore Behavioral Solutions operates residential facilities for youth who have been ordered by the court into juvenile justice facilities. The company has a 20-year history of providing services to at-risk youth, helping young people discover their true core potential to lead productive and rewarding lives. Today, nearly 2,000 TrueCore professionals and staff in facilities across four states offer vital services and support, including alternative education schools and programs for vocational training, substance abuse recovery, behavioral and mental health, and sexual offender treatment.
Stallion Technologies Inc is a Syracuse, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Empower U Inc is a Miami, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Medical Profiles and Engineering is a Eden Prairie, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.